PF-05280602
PF-05280602 Uses, Dosage, Side Effects, Food Interaction and all others data.
PF-05280602 is under investigation in clinical trial NCT01439971 (Phase 1 Safety, Pharmacokinetics And Pharmacodynamics Study Of Recombinant Factor VIIa Variant (813d) In Adult Subjects With Hemophilia).
| Trade Name | PF-05280602 |
| Generic | Marzeptacog alfa (activated) |
| Marzeptacog alfa (activated) Other Names | Marzeptacog alfa (activated), PF-05280602 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here PF-05280602
